Literature DB >> 3874514

Correlation of androgen receptors with histological differentiation in human endometrial carcinomas.

J Kato, T Seto.   

Abstract

Primary endometrial carcinomas from 35 non-treated patients were investigated by measurement of androgen receptors in the tumor cytosols. Receptor analysis was done with a labelled synthetic androgen, methyltrienolone 3H-R1881 and triamcinolone acetonide, and dextran-coated charcoal absorption. The concentrations of androgen receptors in the endometrial carcinomas were, in decreasing order: highly-differentiated tumors, 15.7 +/- 1.8 (fmol/mg protein, mean +/- SE) (number of cases, 21); moderately differentiated tumors, 4.6 +/- 1.6 (n = 7); poorly differentiated tumors, undetectable in 7 out of 8 cases. Highly-differentiated tumors contained a much greater concentration of receptors than the two less differentiated ones. One highly-differentiated endometrial carcinoma with pyometra virtually lacked the receptor. The moderately differentiated endometrial carcinomas contained very low levels of the receptors. The poorly differentiated tumors virtually lacked the receptors. Metastatic lymph nodes from primary endometrial carcinomas with moderate differentiation had a very low receptor level. From these results, it is concluded that human endometrial carcinomas, particularly with histologically high differentiation, contain a considerable amount of androgen receptor and that the receptor concentrations appear to correlate with the histologic grade of tumor differentiation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3874514     DOI: 10.3109/00016348509155114

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  4 in total

1.  Postmenopausal Androgen Metabolism and Endometrial Cancer Risk in the Women's Health Initiative Observational Study.

Authors:  Kara A Michels; Louise A Brinton; Nicolas Wentzensen; Kathy Pan; Chu Chen; Garnet L Anderson; Ruth M Pfeiffer; Xia Xu; Thomas E Rohan; Britton Trabert
Journal:  JNCI Cancer Spectr       Date:  2019-04-25

2.  Androgen receptor as potential therapeutic target in metastatic endometrial cancer.

Authors:  Ingvild Løberg Tangen; Therese Bredholt Onyango; Reidun Kopperud; Anna Berg; Mari K Halle; Anne M Øyan; Henrica M J Werner; Jone Trovik; Karl Henning Kalland; Helga B Salvesen; Camilla Krakstad
Journal:  Oncotarget       Date:  2016-08-02

Review 3.  Molecular Regulation of Androgen Receptors in Major Female Reproductive System Cancers.

Authors:  Sujun Wu; Kun Yu; Zhengxing Lian; Shoulong Deng
Journal:  Int J Mol Sci       Date:  2022-07-08       Impact factor: 6.208

4.  Androgen receptor expression in endometrial carcinoma and its correlation with clinicopathologic features.

Authors:  Atif Ali Hashmi; Zubaida Fida Hussain; Amna Qadri; Muhammad Irfan; Sahar Ramzan; Naveen Faridi; Amir Khan; Muhammad Muzzammil Edhi
Journal:  BMC Res Notes       Date:  2018-05-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.